Ryse Health Raises $3.4M in Seed Funding


Ryse Health, a Baltimore, MD- and Arlington, Va.-based healthtech startup, raised $3.4M in seed funding.

The round was led by W Health Ventures with participation from:

  • LifeBridge Health
  • Healthworx
  • Shantanu Agrawal, MD,
  • John Wray,
  • Kelly Close

Founded by Erin Kane, MD, co-founder and chief medical officer, and Richard Gurley, MBA, co-founder and chief executive officer, Ryse Health provides tech-enabled office-based and virtual care to patients with type 2 diabetes. Its technology platform includes a continuous glucose monitor (CGM) and a custom app to synthesize data, support self-management, and facilitate smooth communication. Their care team comprises health coaches, endocrinologists, and a broad care team of registered dieticians (RDs), certified diabetes care and education specialists (CDCESs), and licensed clinical social workers (LCSWs) to help patients navigate the psychosocial barriers to overcoming chronic disease.

Dr. Kane is a Harvard- and Hopkins-trained physician. She has led multiple care-delivery redesign initiatives, including as an early leader of the Hopkins Capacity Command Center and a GW COVID-19 remote monitoring program. She also has experience as a McKinsey management consultant and a deep understanding of healthcare operations. Mr. Gurley was a leader at two successful value-based, tech-enabled healthcare services startups (Evolent Health and WelbeHealth). He has served as an advisor to seven leading healthcare growth companies, including Doctor on Demand, Modern Fertility and Vera Whole Health. He also has prior experience in McKinsey health payer/provider practice and the Tennessee government.